Literature DB >> 2647292

Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.

M Fukumoto1, R D Estensen, L Sha, G J Oakley, L B Twiggs, L L Adcock, L F Carson, I B Roninson.   

Abstract

A modified in-gel DNA renaturation technique, which detects DNA sequences amplified greater than 7-fold in human DNA, was used to analyze gene amplification in surgical specimens of primary and metastatic ovarian carcinomas. Amplified DNA sequences were detected in two of eight tumors. Hybridization of these samples with different oncogene probes revealed that both tumors contained an amplified Ki-ras gene, which in one case was coamplified with c-myc. In one of the tumors, Ki-ras was found to be amplified in both the primary tumor and three different metastatic nodules. No mutations at codons 12 or 61 of Ki-ras were detected in these tumors. No additional cases of Ki-ras or c-myc amplification were detected by Southern hybridization in the tumors that were found to be amplification negative by modified in-gel renaturation assays. These results indicate that gene amplification in ovarian carcinomas is likely to involve the Ki-ras oncogene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647292

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

Authors:  P A van Dam; I B Vergote; D G Lowe; J V Watson; P van Damme; J C van der Auwera; J H Shepherd
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

2.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

Authors:  J Q Cheng; A K Godwin; A Bellacosa; T Taguchi; T F Franke; T C Hamilton; P N Tsichlis; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.

Authors:  C Somay; T W Grunt; C Mannhalter; C Dittrich
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

4.  Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.

Authors:  M Mandai; I Konishi; T Komatsu; T Mori; S Arao; H Nomura; Y Kanda; H Hiai; M Fukumoto
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

5.  K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.

Authors:  H Suwa; T Yoshimura; N Yamaguchi; K Kanehira; T Manabe; M Imamura; H Hiai; M Fukumoto
Journal:  Jpn J Cancer Res       Date:  1994-10

6.  Infrequent ras mutation in human stomach cancers.

Authors:  M Koshiba; O Ogawa; T Habuchi; S Hamazaki; T Shimada; R Takahashi; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1993-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.